Home / Drug shortages / Sodium Acetate Injection

Sodium Acetate Injection — FDA Drug Shortage

Current — Hospira, Inc., a Pfizer Company

The FDA lists a drug shortage record for Sodium Acetate Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 02/03/2016.

Shortage Details

Status
Current
Company
Hospira, Inc., a Pfizer Company
Package NDC
0409-7299-73
Dosage Form
Injection
Presentation
Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-73)
Initial Posting
02/03/2016
Revised Date

FDA data resources